![Victor W. van Beusechem](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Victor W. van Beusechem
Directeur Technique/Scientifique/R&D chez ORCA Therapeutics BV
Postes actifs de Victor W. van Beusechem
Sociétés | Poste | Début | Fin |
---|---|---|---|
ORCA Therapeutics BV
![]() ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Victor W. van Beusechem
Anciens postes connus de Victor W. van Beusechem
Sociétés | Poste | Début | Fin |
---|---|---|---|
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Directeur Technique/Scientifique/R&D | 01/01/1998 | 01/01/1998 |
Introgene BV | Directeur Technique/Scientifique/R&D | 01/01/1998 | 01/01/1998 |
Formation de Victor W. van Beusechem
University of Leiden | Doctorate Degree |
Vrije Universiteit Amsterdam | Undergraduate Degree |
Statistiques
Internationale
Pays-Bas | 5 |
Royaume-Uni | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
ORCA Therapeutics BV
![]() ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
Introgene BV | Health Technology |
- Bourse
- Insiders
- Victor W. van Beusechem
- Expérience